Skip to Main Content

Author Details

Wenyan Zhong
Oncology R&D
2000
24
14
PMIDPaper TitleJournal TitlePublished Year
36455168Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.J Clin Oncol2023
37517589Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics.Mol Cell Proteomics2023
33356791Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells.Cell Cycle2021
34095881NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.Cell Rep Med2021
32866155GeneTEFlow: A Nextflow-based pipeline for analysing gene and transposable elements expression from RNA-Seq data.PLoS One2020
31898484Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors.BMC Genomics2020
32821942PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residues.Nucleic Acids Res2020
32923161Anti-tumor immunity influences cancer cell reliance upon ATG7.Oncoimmunology2020
30487219Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.Proc Natl Acad Sci U S A2018
28727782Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients.PLoS One2017
27084424Upregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer Cells.Transl Oncol2016
25585957Evolving Strategies for Target Selection for Antibody-Drug Conjugates.Pharm Res2015
26340918Breast cancer cells respond differentially to modulation of TGFβ2 signaling after exposure to chemotherapy or hypoxia.Cancer Res2015
26015513Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.Clin Cancer Res2015
25671303Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.Oncotarget2015
25592564Cell Index Database (CELLX): a web tool for cancer precision medicine.Pac Symp Biocomput2015
22333182Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling.J Mol Endocrinol2012
19279231LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.Am J Physiol Cell Physiol2009
19318684LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.J Lipid Res2009
17123777Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation.Genomics2007
16849326Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase.J Biol Chem2006
12040188A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.Science2002
11181995The sequence of the human genome.Science2001
10731132The genome sequence of Drosophila melanogaster.Science2000
  • 1 - 24 of 24

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 0
Tao Wang
University of Texas Southwestern Medical Center
Career Start Year 2014
Number of shared co-authors 0
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year 2013
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Qi Zhao
University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 4
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 8
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 3
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Zhongwu Lai
Oncology R&D
Co-authored papers 4
N V Mil'shina
Co-authored papers 3
Hui-Juan An
Co-authored papers 3
Keith A Nelson
Massachusetts Institute of Technology
Co-authored papers 3
Peng Guan
College of Veterinary Medicine, Sichuan Agricultural University
Co-authored papers 3
Jennifer R Wortman
Broad Institute of MIT and Harvard
Co-authored papers 3
Carl Dahlke
Co-authored papers 3
Kristina L Dodson
Co-authored papers 3
Zhaoxi Ke
Beijing University of Chinese Medicine
Co-authored papers 3
Mee C Moy
Co-authored papers 3
Knut Reinert
Institut fur Informatik, Freie Universitat Berlin
Co-authored papers 3
Thomas Smith
Flinders Medical Centre
Co-authored papers 3
Jarrett T Houck
Co-authored papers 3
Ying Lei
Co-authored papers 3
Jeannine D Gocayne
National Institute of Neurological and Communicative Disorders and Stroke
Co-authored papers 3
Clark Mobarry
Co-authored papers 3
Carl Fosler
Co-authored papers 3
Karin A Remington
The J. Craig Venter Institute.
Co-authored papers 3
Cheryl L Kraft
Co-authored papers 3
Susanne M Dietz
Co-authored papers 3
Cynthia Andrews-Pfannkoch
Mayo Clinic
Co-authored papers 3
Andrei Gabrielian
National Institutes of Allergy and Infectious Diseases
Co-authored papers 3
Chinnappa D Kodira
GE Global Research Center
Co-authored papers 3
Lisa Doup
Co-authored papers 3
Carlos C Evangelista
Co-authored papers 3
Peter Li
Co-authored papers 3
Bixiong Chris Shue
Co-authored papers 3
Tim Howland
Co-authored papers 3
Mark Yandell
University of Utah
Co-authored papers 3
Eli Venter
Vanderbilt University, Columbia University Medical Center
Co-authored papers 3
Release 1.2